Sources Reveal Biogen is Exploring Sale of Hemophilia Assets Post author:Sam Post published:April 11, 2016 Post category:BioPharma April 11, 2016By Mark Terry, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like BlueRock Therapeutics Sets Up HQ in Cambridge, Expands Executive Team October 25, 2017 CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing May 30, 2017 5 Biotechs Drawing Buyout Buzz in 2018 January 23, 2018
CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing May 30, 2017
